- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04601948
AYActive Study! A Physical Health Activity Intervention
May 11, 2023 updated by: Lucas Carr
The purpose of this pilot study is to explore the feasibility, acceptability, and efficacy of a 6-week mobile health (mHealth) physical activity intervention among adolescent and young adult (AYA) cancer survivors being treated at the University of Iowa Hospitals and Clinics.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this pilot study is to explore the feasibility, acceptability, and efficacy of a 6-week mobile health (mHealth) physical activity intervention among adolescent and young adult (AYA) cancer survivors being treated at the University of Iowa Hospitals and Clinics.
Eligible participants will receive a Fitbit activity monitor and access to the mHealth physical activity intervention for 6 weeks.
The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.
AYA cancer survivors between 13-39 years are invited to participate and the impact of this intervention will be tested over 6 weeks.
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 39 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male and female cancer survivors
- Diagnosed between 13 and 39 years old
- Currently 3-24 months post-treatment (or in maintenance therapy)
- Receiving survivorship care at HCCC/UIHC
- In remission
- Physically able to walk without limitations
- Own a smartphone with a data plan that is also capable of receiving and sending texts
- Able to understand English and provide informed assent/consent
Exclusion Criteria:
- Physically unable to walk without limitations
- Actively receiving cancer treatment
- Does not own a smartphone with a data plan
- Visual or cognitive impairments causing inability to read, complete or sign the consent form and survey
- Participants with diagnosis of thyroid cancer (due to differences in physical, psychological, emotional, and social effects)
- Presence of a psychiatric disorder that is not managed/unstable or suicidal ideation/actuation in preceding 12 months
- Currently meeting physical activity requirements per American Cancer Society guidelines (150 or more minutes per week of moderate to vigorous physical activity)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Participants will receive a Fitbit activity monitor and access to the mHealth physical activity intervention for 6 weeks.
The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.
|
Eligible participants will receive a Fitbit activity monitor and access to our mHealth physical activity intervention for 6 weeks.
The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of steps taken per day
Time Frame: Dail steps will be measured each day of the intervention for 7 weeks
|
Number of steps taken per day on each day of the intervention
|
Dail steps will be measured each day of the intervention for 7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PROMIS Fatigue Scale
Time Frame: Change in fatigue over 7 weeks
|
8 item scale, lower score is better
|
Change in fatigue over 7 weeks
|
PROMISE Pain Scale
Time Frame: Change in pain over 7 weeks
|
8 item scale, lower score is better
|
Change in pain over 7 weeks
|
PROMIS Physical Function Scale
Time Frame: Change in physical function over 7 weeks
|
8 item scale, lower score is better
|
Change in physical function over 7 weeks
|
PROMIS Depression Scale
Time Frame: Change in depression over 7 weeks
|
8 item scale, lower score is better
|
Change in depression over 7 weeks
|
PROMIS Anxiety Scale
Time Frame: Change in anxiety over 7 weeks
|
8 item scale, lower score is better
|
Change in anxiety over 7 weeks
|
Exercise Self-Regulatory Efficacy
Time Frame: Change in exercise self regulatory efficacy over 7 weeks
|
20 item scale, higher score is better
|
Change in exercise self regulatory efficacy over 7 weeks
|
Social Support for exercise
Time Frame: Change in social support for exercise over 7 weeks
|
13 item scale, higher score is better
|
Change in social support for exercise over 7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lucas Carr, PhD, University of Iowa
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 6, 2019
Primary Completion (Actual)
September 4, 2020
Study Completion (Actual)
September 4, 2020
Study Registration Dates
First Submitted
November 18, 2019
First Submitted That Met QC Criteria
October 20, 2020
First Posted (Actual)
October 26, 2020
Study Record Updates
Last Update Posted (Actual)
May 16, 2023
Last Update Submitted That Met QC Criteria
May 11, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 201907702
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
-
University of Wisconsin, MadisonCompletedCancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Healthy Subject | Stage I Colorectal Cancer | Stage IIIA Colorectal Cancer | Stage IIIB Colorectal Cancer | Stage... and other conditionsUnited States
Clinical Trials on mHealth Activity Intervention
-
The Miriam HospitalUnknownStroke | Sedentary Lifestyle | Ischemic Attack, Transient | ExerciseUnited States
-
Vanderbilt University Medical CenterJohns Hopkins UniversityCompletedPulmonary Arterial Hypertension | Idiopathic Pulmonary Arterial Hypertension | Associated Pulmonary Arterial Hypertension | Heritable Pulmonary Arterial HypertensionUnited States
-
Medical College of WisconsinCenters for Disease Control and PreventionCompleted
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of California, San FranciscoAmerican Heart AssociationCompleted
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; Kwong Wah Hospital; University of Glasgow; Tsan Yuk...RecruitingQuality of Life | Family Relations | Postnatal DepressionHong Kong
-
Children's National Research InstituteNot yet recruitingSexually Transmitted Diseases
-
Kaiser PermanenteCompletedSmoking | Smoking CessationUnited States
-
KU LeuvenJomo Kenyatta University of Agriculture and TechnologyCompleted
-
University of FloridaCompleted